Moleculin Biotech, Inc. (MBRX)

USD 1.88

(1.08%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 127 Thousand 222 Thousand 260 Thousand 285 Thousand 185 Thousand 68 Thousand
Gross Profit -127 Thousand -222 Thousand -260 Thousand -285 Thousand -185 Thousand -68 Thousand
Operating Expenses 29.63 Million 30.64 Million 22.96 Million 19.74 Million 17.52 Million 15.02 Million
Selling, General and Administrative Expenses 10.01 Million 11.67 Million 8.38 Million 6.78 Million 6.31 Million 5.29 Million
Research and Development Expenses 19.48 Million 18.96 Million 14.41 Million 12.75 Million 11.01 Million 9.72 Million
Other Expenses 127 Thousand 40 Thousand 164 Thousand 200 Thousand 199 Thousand -40 Thousand
Cost and Expenses 29.63 Million 30.64 Million 22.96 Million 19.74 Million 17.52 Million 15.02 Million
Operating Income -29.63 Million -30.64 Million -22.96 Million -19.74 Million -17.52 Million -15.02 Million
Interest Expense - - - - - -
Income Tax Expense - -1.61 Million -7.03 Million -2.35 Million -229 Thousand 3.14 Million
Earnings before Tax -29.76 Million -29.02 Million -15.89 Million -17.35 Million -13.43 Million -11.87 Million
Net Income -29.76 Million -27.41 Million -8.86 Million -14.99 Million -13.2 Million -11.87 Million
Earnings Per Share Basic -15.07 -14.37 -4.94 -22.85 -29.18 -41.26
Earnings Per Share Diluted -15.07 -14.37 -4.94 -22.85 -29.18 -41.26
Weighted Average Shares Outstanding 1.97 Million 1.9 Million 1.79 Million 656.37 Thousand 452.46 Thousand 287.82 Thousand
Weighted Average Shares Outstanding (Diluted) 1.97 Million 1.9 Million 1.79 Million 656.37 Thousand 452.46 Thousand 287.82 Thousand
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -29.5 Million -30.51 Million -22.8 Million -19.54 Million -13.24 Million -14.95 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts